Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Cash & Equivalents (2022 - 2025)

OneMedNet (ONMD) has disclosed Cash & Equivalents for 4 consecutive years, with $541000.0 as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 81.01% to $541000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $541000.0 through Dec 2025, down 81.01% year-over-year, with the annual reading at $541000.0 for FY2025, 81.01% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $541000.0 at OneMedNet, up from $149000.0 in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.8 million in Q4 2024, with the low at $47000.0 in Q4 2023.
  • Average Cash & Equivalents over 4 years is $620811.2, with a median of $234923.0 recorded in 2022.
  • The sharpest move saw Cash & Equivalents skyrocketed 5961.7% in 2024, then tumbled 92.3% in 2025.
  • Over 4 years, Cash & Equivalents stood at $271000.0 in 2022, then crashed by 82.66% to $47000.0 in 2023, then surged by 5961.7% to $2.8 million in 2024, then plummeted by 81.01% to $541000.0 in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $541000.0, $149000.0, and $122000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.